Activating Mutations − Receptor Lung Adenocarcinoma with Epidermal Growth Factor Hepatocyte Growth Factor Induces Gefitinib Resistance of Updated

Article

Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands (2008).

High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor (2005)

Article

Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (egfr) mutations with the classical mutation pattern (1634).

Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (egfr) mutations with the classical mutation pattern (2014).

Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with poor response to gefitinib: A case report.

Article

Growth factor-1 receptor inhibitor (bms-536924) and (2009).

Small cell lung cancer with an epidermal growth factor receptor mutation in primary gefitinib-resistant adenocarcinoma of the lung

Tumor Growth (2008)

Article